# Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy

> **NCT03037892** · NA · COMPLETED · sponsor: **King Hamad University Hospital, Bahrain** · enrollment: 75 (actual)

## Conditions studied

- Colonoscopy

## Interventions

- **DRUG:** Midazolam, Fentanyl
- **DRUG:** Midazolam, Remifentanil
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT03037892
- **Lead sponsor:** King Hamad University Hospital, Bahrain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03037892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03037892, "Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03037892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*